[{'Item': [], 'Id': '103820', 'AssayName': 'Inhibition of non-specific binding effects in human plasma at a concentration of 100 nM; NT means not tested', 'AssayDescription': 'Title: Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidones._||_Abstract: A series of 1-(biphenylmethylamidoalkyl)-pyrimidones has been designed as nanomolar inhibitors of recombinant lipoprotein-associated phospholipase A(2) with high potency in whole human plasma. 5-(Pyrazolylmethyl) derivative 16 and 5-(methoxypyrimidinylmethyl) derivative 27 demonstrated excellent pharmacodynamic profiles which correlated well with their pharmacokinetic effects.', 'ReadoutCount': NoneElement(attributes={}), 'SourceNameList': ['ChEMBL'], 'ActiveSidCount': IntegerElement(0, attributes={}), 'ActivityOutcomeMethod': '', 'InactiveSidCount': NoneElement(attributes={}), 'InconclusiveSidCount': NoneElement(attributes={}), 'TotalSidCount': IntegerElement(1, attributes={}), 'XRefDburlList': [], 'XRefAsurlList': [], 'ModifyDate': '2022/03/18 00:00', 'DepositDate': '2010/05/20 00:00', 'HoldUntilDate': '1/01/01 00:00', 'AID': IntegerElement(103820, attributes={}), 'TotalCidCount': NoneElement(attributes={}), 'ActiveCidCount': NoneElement(attributes={}), 'ProteinTargetList': [{'Name': 'Platelet-activating factor acetylhydrolase', 'GI': IntegerElement(2497687, attributes={})}]}]
